The SIPPET study: what impact will it have on haemophilia care?

References

1. Peyvandi F, Mannucci PM, Garagiola I, et al. Source of Factor VIII Replacement (plasmatic or recombinant) and Incidence of Inhibitory Alloantibodies in Previously Untreated Patients with Severe Hemophilia a: The Multicenter Randomized Sippet Study. Presented at American Society
Search in Google Scholar Back to article
of Hematology. December, 2015. https://ash.confex.com/ash/2015/webprogram/Paper82866.html
Search in Google Scholar Back to article
2. Gouw SC, van den Berg HM, Fischer K, et al; PedNet and Research of Determinants of INhibitor development (RODIN) Study Group. Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study. Blood 2013; 121(20): 4046-55. doi: 10.1182/blood-2012-09-457036.
Open DOI Search in Google Scholar Back to article
3. Andrea Messori A. The SIPPET trial and the economic consequences of developing high-titre inhibitors in hemophilia A. BMJ 2015; 350:h870
Search in Google Scholar Back to article